Mammalian cell PtdIns (phosphatidylinositol) in vivo is enriched in the sn-1-stearoyl 2-arachidonoyl species, the physiological precursor of phosphatidylinositol 4,5-bisphosphate. Mechanisms regulating this specificity are unclear but are typically lost for cells in culture. We used ESI-MS (tandem electrospray ionization-mass spectrometry) to determine the molecular species of PtdIns synthesized by mouse tissues in vivo compared with cultured cells in vitro. After incorporation of deuteriated myo-d 6 -inositol over 3 h, endogenous and newly synthesized PtdIns and lysoPtdIns species were quantified from precursor scans of m/z 241 − and m/z 247 − respectively. PtdIns was synthesized as a wide range of species irrespective of the final membrane composition. Analyses of isotope enrichments argued against acyl remodelling as the major regulatory mechanism: composition of the lysoPtdIns pool under all conditions reflected that of either endogenous or newly synthesized PtdIns and was always at equilibrium. The kinetics of PtdIns synthesis, together with the prolonged time scale required for achieving final equilibrium compositions suggest that selective transport between membranes and/or hydrolysis of selected molecular species are the most probable mechanisms regulating compositions of PtdIns and, ultimately, phosphatidylinositol 4,5-bisphosphate.
Introduction
Mammalian cells in vivo maintain a remarkably consistent and simple molecular species composition of membrane PtdIns (phosphatidylinositol), dominated by a single species containing stearate (18:0) at the sn-1 and arachidonate (20:4n-6) at the sn-2 position [1] . In contrast, the dominant membrane phospholipids PtdCho (phosphatidylcholine) and phosphatidylethanolamine are much more complex, comprising in excess of 30-50 molecular species [2] . Evidence suggests that the specificity of PtdIns composition is functionally associated with the intracellular signalling functions of polyphosphoinositides. Therefore phosphatidylinositol 4,5-bisphosphate is synthesized from PtdIns and hydrolysed by PtdIns-specific phospholipase C to generate the second messengers DAG (diacylglycerol) and inositol trisphosphate [3] and the precise molecular species composition of DAG mobilized appears to be critical for activation of DAG-sensitive isoforms of protein kinase C [4] .
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The mechanisms whereby cells acquire and maintain this composition of PtdIns are not well understood and cells in culture tend to lose this specificity. Acyl remodelling reactions are integral to PtdCho synthesis de novo in many tissues [5] where selective lipase actions generate lyso-PtdCho intermediates that are then reacylated to generate equilibrium PtdCho compositions. Similar mechanisms at sn-1 and sn-2 positions of liver PtdIns have been proposed [6, 7] but their molecular specificity in vivo has not been systematically investigated. Moreover, it is uncertain whether synthetic mechanisms identified in liver are generally applicable to other cell types.
Here we used ESI-MS (electrospray ionization-mass spectrometry), previously shown to be effective for analysing choline-d 9 incorporation into newly synthesized PtdCho in vitro and in vivo [8, 9] , to define incorporation patterns of deuteriated myo-d 6 -inositol into molecular species of PtdIns and lysoPtdIns. Comparison of newly synthesized and endogenous PtdIns and lysoPtdIns molecular species compositions permitted calculation of relative incorporation rates of deuteriated label. Relative enrichments in turn allowed assessment of whether obligatory remodelling of all newly synthesized PtdIns via lysoPtdIns determined the pattern of PtdIns synthesis in mouse tissues in vivo and in a range of cultured mammalian cells in vitro. 
Materials and methods
myo-d 6 -Inositol was obtained from C/D/N Isotopes Inc (Pointe-Claire, Quebec, Canada), organic solvents were from Fisher Scientific (Loughborough, Leics., U.K.) and aminopropyl BondElut sample preparation cartridges (100 mg) were obtained from Phenomenex (Macclesfield, Cheshire, U.K.). PtdIns internal standard was from Avanti Polar Lipids (Alabaster, AL, U.S.A.). Human IMR-32 neuroblastoma cells, Jurkat T-lymphoma cells and, CHO-K1 (where CHO stands for Chinese-hamster ovary) cells were cultured in 75 cm 2 flasks in Dulbecco's modified Eagle's medium containing 25 mM Hepes and fetal bovine serum at 10% (5% for CHO-K1 cells). Subconfluent cells were labelled with myod 6 -inositol for up to 3 h as described elsewhere [10] . Black CB6 mice were injected intraperitoneally with 1 mg of myod 6 -inositol in 200 µl saline for 3 h before killing and tissue removal and storage at −20
• C. After subsequent cell/tissue lipid extraction [11] and phospholipid class purification by solid-phase extraction [8] , ESI-MS/MS of endogenous and newly synthesized PtdIns in the acidic phospholipid fraction was undertaken on a Micromass Ultima Quatro electrospray ionization tandem mass spectrometer by direct injection employing precursor scans of m/z 241 − and m/z 247 − as described previously [8] and lysoPtdIns species were incorporated into the analyses by extending the scans to encompass the range of masses from m/z 500 to 1000.
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